|
1.
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Allemani C, Weir HK, Carreira H, et al:
Global surveillance of cancer survival 1995–2009: Analysis of
individual data for 25,676,887 patients from 279 population-based
registries in 67 countries (CONCORD-2). Lancet. 385:977–1010. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Haverkamp L, Brenkman HJ, Seesing MF,
Gisbertz SS, van Berge Henegouwen MI, Luyer MD, Nieuwenhuijzen GA,
Wijnhoven BP, van Lanschot JJ, de Steur WO, et al: Laparoscopic
versus open gastrectomy for gastric cancer, a multicenter
prospectively randomized controlled trial (LOGICA-trial). BMC
Cancer. 15:5562015. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Yang S, Feng R, Pan ZC, Jiang T, Xu Q and
Chen Q: A comparison of intravenous plus intraperitoneal
chemotherapy with intravenous chemotherapy alone for the treatment
of gastric cancer: A meta-analysis. Sci Rep. 5:125382015.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Hakomori S: Tumor malignancy defined by
aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer
Res. 56:5309–5318. 1996.PubMed/NCBI
|
|
6.
|
Hakomori S: Glycosylation defining cancer
malignancy: New wine in an old bottle. Proc Natl Acad Sci USA.
99:10231–10233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Moniaux N, Andrianifahanana M, Brand RE
and Batra SK: Multiple roles of mucins in pancreatic cancer, a
lethal and challenging malignancy. Br J Cancer. 91:1633–1638.
2004.PubMed/NCBI
|
|
8.
|
Dennis JW, Granovsky M and Warren CE:
Glycoprotein glycosylation and cancer progression. Biochim Biophys
Acta. 1473:21–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Li D, Mallory T and Satomura S: AFP-L3: A
new generation of tumor marker for hepatocellular carcinoma. Clin
Chim Acta. 313:15–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Meany DL and Chan DW: Aberrant
glycosylation associated with enzymes as cancer biomarkers. Clin
Proteomics. 8:72011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Debruyne EN, Vanderschaeghe D, Van
Vlierberghe H, Vanhecke A, Callewaert N and Delanghe JR: Diagnostic
value of the hemopexin N-glycan profile in hepatocellular carcinoma
patients. Clin Chem. 56:823–831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Meezan E, Wu HC, Black PH and Robbins PW:
Comparative studies on the carbohydrate-containing membrane
components of normal and virus-transformed mouse fibroblasts. II.
Separation of glycoproteins and glycopeptides by sephadex
chromatography. Biochemistry. 8:2518–2524. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Dube DH and Bertozzi CR: Glycans in cancer
and inflammation-potential for therapeutics and diagnostics. Nat
Rev Drug Discov. 4:477–488. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Fairweather M, Jajoo K, Sainani N,
Bertagnolli MM and Wang J: Accuracy of EUS and CT imaging in
preoperative gastric cancer staging. J Surg Oncol. 111:1016–1020.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Jee HB, Park MJ, Lee HS, Park MS, Kim MJ
and Chung YE: Is non-contrast CT adequate for the evaluation of
hepatic metastasis in patients who cannot receive iodinated
contrast media? PLoS One. 10:e01341332015. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Grabinska K, Pelak M, Wydmanski J,
Tukiendorf A and d'Amico A: Prognostic value and clinical
correlations of 18-fluorodeoxyglucose metabolism quantifiers in
gastric cancer. World J Gastroenterol. 21:5901–5909.
2015.PubMed/NCBI
|
|
17.
|
He P, Zhang M and Yuan F: The significance
of detecting tumor abnormal protein in patients with lung cancer. J
Hebei Med Univ. 10:1225–1226. 2012.
|
|
18.
|
Deng K, Yang L, Hu B, Wu H, Zhu H and Tang
C: The prognostic significance of pretreatment serum CEA levels in
gastric cancer: A meta-analysis including 14651 patients. PLoS One.
10:e01241512015. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Zou L and Qian J: Decline of serum CA724
as a probable predictive factor for tumor response during
chemotherapy of advanced gastric carcinoma. Chin J Cancer Res.
26:404–409. 2014.PubMed/NCBI
|
|
20.
|
Zhu YB, Ge SH, Zhang LH, Wang XH, Xing XF,
Du H, Hu Y, Li YA, Jia YN, Lin Y, et al: Clinical value of serum
CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of
gastric cancer. Chin J Gastrointest Surg. 15:161–164. 2012.(In
Chinese).
|
|
21.
|
Li F, Li S, Wei L, Liang X, Zhang H and
Liu J: The correlation between pre-operative serum tumor markers
and lymph node metastasis in gastric cancer patients undergoing
curative treatment. Biomarkers. 18:632–637. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Jing JX, Wang Y, Xu XQ, Sun T, Tian BG, Du
LL, Zhao XW and Han CZ: Tumor markers for diagnosis, monitoring of
recurrence and prognosis in patients with upper gastrointestinal
tract cancer. Asian Pac J Cancer Prev. 15:10267–10272. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Ji LY: Tumor abnormal protein (TAP)
Application of screening for early cancer. China Health Care
Nutrition. 10:591–592. 2013.
|
|
24.
|
Jin H, Zhan HG and Cui X: Evaluation of
the effectiveness of tumor abnormal protein detection system in
digestive cancer. Mod Med J. 4:270–271. 2006.
|
|
25.
|
Miyake M, Taki T, Hitomi S and Hakomori S:
Correlation of expression of H/Le(y)/Le(b) antigens with survival
in patients with carcinoma of the lung. N Engl J Med. 327:14–18.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Nakamori S, Kameyama M, Imaoka S, Furukawa
H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y and
Irimura T: Increased expression of sialyl Lewisx antigen correlates
with poor survival in patients with colorectal carcinoma:
Clinicopathological and immunohistochemical study. Cancer Res.
53:3632–3637. 1993.PubMed/NCBI
|
|
27.
|
Krug LM, Ragupathi G, Ng KK, Hood C,
Jennings HJ, Guo Z, Kris MG, Miller V, Pizzo B, Tyson L, et al:
Vaccination of small cell lung cancer patients with polysialic acid
or N-propionylated polysialic acid conjugated to keyhole limpet
hemocyanin. Clin Cancer Res. 10:916–923. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Holmberg LA and Sandmaier BM: Vaccination
with Theratope (STn-KLH) as treatment for breast cancer. Expert Rev
Vaccines. 3:655–663. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Shao JY and Shi NF: Analysis of early
malignant tumor using tumor abnormal protein screening. Dis
Surveill. 09:6452007.
|
|
30.
|
Wu XY and Huang XE: Clinical application
of serum tumor abnormal protein (TAP) in colorectal cancer
patients. Asian Pac J Cancer Prev. 16:3425–3428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Liu J and Huang XE: Clinical application
of serum tumor abnormal protein from patients with gastric cancer.
Asian Pac J Cancer Prev. 16:4041–4044. 2015. View Article : Google Scholar : PubMed/NCBI
|
